Roche drug scores label expansion for earlier use in lung cancer

The latest stories trending on MedCity News.

Editor's Pick

Top Story Roche Drug Scores Label Expansion for Earlier Use in Lung Cancer The FDA expanded the approval of Roche's Alecensa to include adjuvant treatment of non-small cell lung cancer. The targeted therapy addresses cancers driven by the ALK genetic mutation. Time is Running Out! Act fast! Advance Rate Tickets for MedCity INVEST 2024 end on April 26. Connect with industry leaders, explore cutting-edge investment trends, and create lasting relationships at this exclusive event. Secure your spot today and get ready to unlock new opportunities in healthcare innovation! Get Your Tickets NOW

Featured News

NIH Study: Use of Popular Pain Reliever During Pregnancy Not Linked to Neuro Disorders in Kids Questions about whether acetaminophen use during pregnancy can lead children to develop neurological problems have sparked scientific inquiry and litigation. Lawsuits are continuing, but a new National Institutes of Health-sponsored study has results that show no causal link between acetaminophen and neurodevelopmental disorders. Solera Health Expands Platform To Address Cardiometabolic Conditions Solera Health added Ciba Health, Digbi Health and Wondr Health to its HALO platform. The companies treat conditions like hypertension and diabetes.

Resources

MedCity Debunked: Change Healthcare Cybersecurity Attack, 23andMe Relevance and Startup Tips In this month's episode, we talk about the massive cyberattack at Change Healthcare that brought the healthcare payment processing clearinghouse to its knees. How were providers, patients, pharmacies, and health systems affected? We also talk about 23AndMe and its relevance in the marketplace. Finally, as a journalist and investor, we offer advice to startups on what is a turn-off for us.  Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe